Adverse Effects of Collagenase in the Treatment of Dupuytren Disease: A Systematic Review.
- Published in:
- BioDrugs, 2017, v. 31, n. 2, p. 105, doi. 10.1007/s40259-017-0211-z
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2017 AND VI 31 AND IP 2
Results: 6
1
2
Pathogen Safety of a New Intravenous Immune Globulin 10% Liquid.
- Published in:
- BioDrugs, 2017, v. 31, n. 2, p. 125, doi. 10.1007/s40259-017-0212-y
- By:
- Publication type:
- Article
3
Adalimumab: A Review in Non-Infectious Non-Anterior Uveitis.
- Published in:
- BioDrugs, 2017, v. 31, n. 2, p. 135, doi. 10.1007/s40259-017-0213-x
- By:
- Publication type:
- Article
4
Impact of Guidance on the Prescription Patterns of G-CSFs for the Prevention of Febrile Neutropenia Following Anticancer Chemotherapy: A Population-Based Utilization Study in the Lazio Region.
- Published in:
- BioDrugs, 2017, v. 31, n. 2, p. 117, doi. 10.1007/s40259-017-0214-9
- By:
- Publication type:
- Article
5
Interleukin-5 Inhibitors for Severe Asthma: Rationale and Future Outlook.
- Published in:
- BioDrugs, 2017, v. 31, n. 2, p. 93, doi. 10.1007/s40259-017-0215-8
- By:
- Publication type:
- Article
6
Interchangeability of Biosimilars: A European Perspective.
- Published in:
- BioDrugs, 2017, v. 31, n. 2, p. 83, doi. 10.1007/s40259-017-0210-0
- By:
- Publication type:
- Article